Alzheimer’s disease
-
PublishedJuly 9, 2021
FDA chief calls for investigation into review of controversial new Alzheimer’s drug
It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.
-
PublishedJuly 8, 2021
FDA reverses itself under pressure, moves to limit use of new Alzheimer’s drug
The Food and Drug Administration says the change is intended to address confusion among physicians and patients about who should get Aduhelm, which has faced an intense public backlash since its approval last month.
-
PublishedJuly 2, 2021
Commentary: The Alzheimer’s mistake by the FDA is already getting worse
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence.
-
PublishedJuly 2, 2021
Our View: With Silver Alerts increasing in Maine, it’s time for a closer look
Since the program was established in 2011, it has helped dozens of missing older Mainers get home. But we don't know a lot more about its effectiveness.
-
PublishedJune 23, 2021
Commentary: Medicare must study unproven, expensive Alzheimer’s drug
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective.
-
PublishedJune 20, 2021
Controversial new Alzheimer’s drug gives patients in Maine hope
The treatment developed by Biogen could slow its progression, but health professionals and researchers are divided on whether the FDA was right to approve it.
-
PublishedJune 12, 2021
Another View: Alzheimer’s drug furor highlights U.S. health system’s failures
Is aducanumab a breakthrough or a boondoggle? U.S. health policy offers reason to worry.
-
PublishedJune 7, 2021
FDA approves new drug for Alzheimer’s that experts doubt will work
The decision is sure to spark disagreements among doctors, medical researchers and patient groups, and have far-reaching implications for the standards used to evaluate experimental therapies.
-
PublishedFebruary 14, 2021
Maine Voices: A different way to say ‘I love you’
As Tony Bennett has shown us, Alzheimer’s disease doesn’t dim the gift of or the joy in music.
-
PublishedAugust 12, 2020
Midcoast respite care center to open new location after closing amid pandemic
The nonprofit provides activities for people with dementia and Alzheimer's disease and resources such as support groups, community education and one-on-one counseling for caretakers.